Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice.
10.19540/j.cnki.cjcmm.20191105.501
- Author:
Lian-Xin WANG
1
;
Qing MIAO
2
;
Yan-Ming XIE
1
;
Da-Can CHEN
3
;
Su-Lun SUN
4
;
Hong-Chun ZHANG
5
;
Zhong-Wu JIA
6
;
Tie-Nan LI
7
;
Jia ZHU
8
;
Li-Qing SHI
9
;
Ping SONG
10
;
Feng GAO
6
;
Bao-Lin WEI
11
;
Cui-Ling FENG
12
;
Yi-Qing QU
13
;
Ni-Ni QU
14
;
Xue-Feng YU
15
;
Nian-Zhi ZHANG
16
;
Xue-Qing YU
17
Author Information
1. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. Xiyuan Hospital,China Academy of Chinese Medical Sciences Beijing 100091,China.
3. Guangdong Province Hospital of Chinese Medicine Guangzhou 510530,China.
4. Dongzhimen Hospital,Beijing University of Chinese Medicine Beijing 100700,China.
5. China-Japan Friendship Hospital Beijing 100029,China.
6. Wangjing Hospital,China Academy of Chinese Medical Sciences Beijing 100102,China.
7. Shenyang Integrative Medicine Hospital Shenyang 110031,China.
8. Jiangsu Province Hospital of Chinese Medicine Nanjing 210029,China.
9. Dongfang Hospital,Beijing University of Chinese Medicine Beijing 100078,China.
10. China Academy of Chinese Medical Sciences Beijing 100700,China.
11. the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medical Tianjin 300150,China.
12. People's Hospital of Peking University Beijing 100044,China.
13. Qilu Hospital of Shandong University Jinan 200240,China.
14. the Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110141,China.
15. the First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang 110031,China.
16. the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine Hefei 230031,China.
17. the First Affiliated Hospital of Henan University of Chinese Medicine Zhengzhou 450004,China.
- Publication Type:Journal Article
- Keywords:
GRADE;
Pudilan Xiaoyan Oral Liquid;
expert consensus practice;
recommendation
- MeSH:
China;
Consensus;
Drugs, Chinese Herbal/therapeutic use*;
Humans;
Medicine, Chinese Traditional;
Nonprescription Drugs
- From:
China Journal of Chinese Materia Medica
2019;44(24):5277-5281
- CountryChina
- Language:Chinese
-
Abstract:
Pudilan Xiaoyan Oral Liquid has effects in clearing away heat and detoxifying,and is used to treat pharynx and throat swelling caused by the syndrome of excessive heat and toxin accumulation. Its efficacy is to relieve swelling and pain( redness,swelling and hot pain). It is included in the Chinese Pharmacopoeia of 2015 Edition,and has been listed in provincial health insurance directories of Shaanxi,Jiangsu,Liaoning,Hunan,Tianjin,Xinjiang and Hebei. It has been recommended by health departments of Beijing,Chongqing and other provinces as a preferred drug for the prevention and treatment of H1 N1 and HFMD,and listed in the diagnosis and Treatment Guide of HFMD by the Ministry of Health,the Clinical Application Guide of Chinese Patent Medicine edited by the Lung Department Disease Branch of China Association of Chinese Medicine,and the Clinical Practice Guide of Single Administration/Combined Administration of Antibiotics in Treatment of Common Infectious Diseases by China Association of Chinese Medicine. To further improve the clinician's understanding of drugs and better guide the rational clinical application,we invited front-line clinical experts from respiratory department,infectious department and dermatology of traditional Chinese and Western medicine to develop and compile the expert consensus. The consensus fully considered the clinical evidence and the expert clinical experience to give recommendations for clinical problems with evidence support and consensus suggestions for clinical problems without evidence support by the nominal group method.This consensus is based on clinical research evidence and expert experience in a simple and clear format,which provides a preliminary reference for the clinical use of the drug.
